特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
850296

世界の単核症診断市場:成長、動向、予測

Mononucleosis Diagnostic Market - Growth, Trends, and Forecast (2019 - 2024)

出版日: | 発行: Mordor Intelligence LLP | ページ情報: 英文 112 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.56円
世界の単核症診断市場:成長、動向、予測
出版日: 2019年02月01日
発行: Mordor Intelligence LLP
ページ情報: 英文 112 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の単核症診断市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場動向

  • 市場概要
  • 促進因子
    • 患者の間の医療に関する認識と知識の向上
    • 診断迅速化につながる技術進歩
    • 成人人口の増加
  • 阻害因子
    • 単核症診断のための利用可能な試験の制限
  • ポーターズファイブフォース分析

第5章 市場セグメンテーション

  • 検査タイプ別
    • モノスポット検査
    • 全血球数検査
    • エプスタイン・バー・ウイルス(EBV)抗体検査
  • エンドユーザー別
    • 病院
    • 試験所
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合環境

  • 企業プロファイル
    • Abbott Laboratories
    • Arlington Scientific Inc.
    • Beckman Coulter Inc.
    • Bio-Rad Laboratories Inc.
    • Cardinal Health Inc.
    • Immunostics Inc.
    • Meridian Bioscience
    • Quidel Corporation
    • Sekisui Diagnostics
    • Thermo Fischer Scientific Inc.

第7章 市場の機会と将来動向

目次
Product Code: 66031

Market Overview

The major factors that are responsible for the growth of the global mononucleosis diagnostics market include the rising health awareness and knowledge among patients, technological advancements leading to faster diagnosis, and the rise in the adolescent population. These factors are expected to further contribute to the growth of the market in the forecast period.

Mononucleosis is an infectious disease caused due to the Epstein-Barr virus (EBV), with infection typically occurring in teenagers. This virus can spread through the saliva. If anyone gets EBV, they may probably become immune to mononucleosis for the rest of their life. The rising awareness and knowledge about mononucleosis are driving the growth of the market. The virus that causes mononucleosis plays a role in the development of various types of head and neck cancer, thereby leading to awareness among the general population. Furthermore, there is an increase in the adolescent population across the world, particularly in Southeast Asia, which is expected to drive the overall growth of the market. As mononucleosis occurs in younger people, the large patient pool is expected to create tremendous opportunities for the market. According to the estimates of the United States Census Bureau, in 2017, there were 41,910,114 people aged between 10-19 in the United States, which is approximately 13% of the total population. In addition, according to the data published by the United Nations Population Fund (UNPF), an estimated 60% of the population in Sub-Saharan Africa is below the age of 25.

Scope of the Report

As per the scope of the report, mononucleosis diagnostics refers to the detection of the Epstein-Barr virus (EBV). The market comprises various detection tests used for the diagnosis of mononucleosis. There are various tests available in the market, such as the monospot test, complete blood count test, and Epstein Barr virus (EBV) antibody test. Furthermore, the market is segmented by the end user, which is further sub-segmented into hospitals, laboratories, and other end users.

Key Market Trends

Monospot Test Segment by Test Type is Expected to Hold the Largest Market Share during the Forecast Period

A monospot test, also known as a heterophile antibody test, is a rapid test for the detection of infectious mononucleosis caused due to Epstein-Barr virus (EBV). This test is expected to hold the largest market share, owing to the benefits associated with the test, such as non-interference with other tests, accurate results, rapid detection of antibodies, and cost-effectiveness. The monospot test can be used in the detection of other diseases with similar symptoms, such as HIV, cytomegalovirus infection, and strep throat. Serological tests are the most common types of tests performed by the doctors to assign stage-specific treatments to patients. The major market players are focusing on the development of advanced products, which is expected to boost market growth. Furthermore, the rising disease prevalence and the increase in awareness and knowledge regarding the disease are expected to drive the growth of this segment over the forecast period.

Asia-Pacific Accounted for the Highest Growth Rate in the Global Market

The Asia-Pacific region holds the highest growth rate for the mononucleosis diagnostic market, and it is expected to show a similar trend over the forecast period, without significant fluctuations. The rising adolescent population in the region is one of the major factors that is expected to drive the growth of the market over the forecast period. As per the estimates of UNICEF, more than half of all adolescents across the world live in Asia, while South Asia is home to the largest number of adolescents in any region in the world (around 340 million ). South Asia is followed by East Asia and the Pacific, with around 277 million. Thus, owing to the number of adolescents, the region is expected to hold tremendous market opportunities over the forecast period.

Competitive Landscape

The global mononucleosis diagnostics market is dominated by both major and small players. However, there are only a few small market players present in the niche segment of the market. The major market players are focusing on the development of advanced products in order to achieve faster detection.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Health Awareness and Knowledge among Patients
    • 4.2.2 Technological Advancements Leading to Faster Diagnosis
    • 4.2.3 Rise in the Adolescent Population
  • 4.3 Market Restraints
    • 4.3.1 Limitations of Available Tests for the Diagnosis of Mononucleosis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type of Test
    • 5.1.1 Monospot Test
    • 5.1.2 Complete Blood Count Test
    • 5.1.3 Epstein Barr Virus (EBV) Antibody Test
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Laboratories
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 US
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 UK
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East & Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Arlington Scientific Inc.
    • 6.1.3 Beckman Coulter Inc.
    • 6.1.4 Bio-Rad Laboratories Inc.
    • 6.1.5 Cardinal Health Inc.
    • 6.1.6 Immunostics Inc.
    • 6.1.7 Meridian Bioscience
    • 6.1.8 Quidel Corporation
    • 6.1.9 Sekisui Diagnostics
    • 6.1.10 Thermo Fischer Scientific Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.